Trial site
Huizhou Municipal Central Hospital
- 10running trials
- 11closed trials
The trials here
What the 21 trials at this site are about, from their registry records.
- Conditions
- Type 2 diabetes7 trials
- Lung cancer6 trials
- Deep vein thrombosis and pulmonary embolism2 trials
- Stroke2 trials
- Cervical cancer1 trial
- Coronary artery disease1 trial
- Diffuse large B-cell lymphoma1 trial
- Ulcerative colitis1 trial
- Phase
- Phase 314 trials
- Phase 23 trials
- Phase 1/21 trial
- Status
- Completed9 trials
- Active, not recruiting6 trials
- Recruiting3 trials
- Terminated2 trials
- Not yet recruiting1 trial
- Lead sponsor
- Janssen Research & Development, LLC7 trials
- Eli Lilly and Company4 trials
- Shenzhen HighTide Biopharmaceutical Ltd.3 trials
- Anthos Therapeutics, Inc.2 trials
- Nanfang Hospital, Southern Medical University2 trials
- and 3 more
Running trials
Recruiting
Active, not recruiting
Not yet recruiting
Association of Osmotic Drugs With Clinical Outcomes in Acute Large Hemispheric Infarction
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Stroke2 recruiting
- Lung cancer1 recruiting
- Ulcerative colitis1 recruiting
Closed trials
Completed
Completed
Completed
Efficacy and Safety of Berberine Ursodeoxycholate (HTD1801) in Patients With Type 2 Diabetes
Completed
Completed
A Study of Tirzepatide (LY3298176) in Chinese Participants With Type 2 Diabetes (SURPASS-CN-MONO)
Completed
Completed
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome
Completed
A Study of Tirzepatide (LY3298176) in Chinese Participants With Type 2 Diabetes
Terminated
Terminated
A Study Comparing Abelacimab to Apixaban in the Treatment of Cancer-associated VTE
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026